The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials.

Diabetes Obes Metab. 2022;24:281-288

Zobel EH, von Scholten BJ, Hansen TW, Persson F, Rasmussen S, Wolthers B, Rossing P